Matches in SemOpenAlex for { <https://semopenalex.org/work/W4366224579> ?p ?o ?g. }
Showing items 1 to 82 of
82
with 100 items per page.
- W4366224579 abstract "Background: Immune-checkpoint inhibitors (ICIs) have revolutionized the treatment of advanced non-small cell lung cancer (NSCLC), however are frequently associated with thyroid immune-related adverse events (IRAEs). We investigated the association between patient characteristics, tumor PD-L1 expression and molecular profile with the development of thyroid IRAEs in NSCLC patients. Methods: Single center, retrospective study including 107 NSCLC patients treated with PD-1/PD-L1 inhibitors from April 2016 to July 2020. All patients were euthyroid at baseline with at least two TSH measurements post-treatment initiation. The primary outcome was the difference in tumor PD-L1 expression in patients who developed any thyroid IRAEs versus those who remained euthyroid. Additional outcomes included development of overt thyroid dysfunction, the association of specific molecular alterations with thyroid IRAEs, and onset of thyroid IRAEs as a function of tumor PD-L1 expression. Results: Overall, 37 (34.6%) patients developed any thyroid dysfunction and 18 (16.8%) developed overt thyroid dysfunction. Tumor PD-L1 staining intensity was not associated with thyroid IRAEs. TP53 mutation was less likely to be associated with any thyroid dysfunction (p < 0.05) and no association was found between EGFR, ROS, ALK or KRAS mutations. There was no association between PD-L1 expression and time to develop thyroid IRAEs. Conclusion: PD-L1 expression is not associated with the development of thyroid dysfunction in advanced NSCLC patients treated with ICIs, suggesting that thyroid IRAEs are unrelated to tumor PD-L1 expression." @default.
- W4366224579 created "2023-04-19" @default.
- W4366224579 creator A5002146164 @default.
- W4366224579 creator A5012053129 @default.
- W4366224579 creator A5017605264 @default.
- W4366224579 creator A5028018613 @default.
- W4366224579 creator A5048901694 @default.
- W4366224579 date "2023-04-17" @default.
- W4366224579 modified "2023-10-18" @default.
- W4366224579 title "Tumor PD-L1 expression and molecular profiling are not associated with immune checkpoint inhibitor-induced thyroid dysfunction in advanced NSCLC patients" @default.
- W4366224579 cites W1494696914 @default.
- W4366224579 cites W1984273763 @default.
- W4366224579 cites W2040881358 @default.
- W4366224579 cites W2179179825 @default.
- W4366224579 cites W2523528921 @default.
- W4366224579 cites W2527905628 @default.
- W4366224579 cites W2560876009 @default.
- W4366224579 cites W2561156916 @default.
- W4366224579 cites W2625684877 @default.
- W4366224579 cites W2769908638 @default.
- W4366224579 cites W2786403629 @default.
- W4366224579 cites W2793364080 @default.
- W4366224579 cites W2794031826 @default.
- W4366224579 cites W2796582438 @default.
- W4366224579 cites W2898946138 @default.
- W4366224579 cites W2940955228 @default.
- W4366224579 cites W2995789098 @default.
- W4366224579 cites W3000319768 @default.
- W4366224579 cites W3004708552 @default.
- W4366224579 cites W3004813841 @default.
- W4366224579 cites W3011058953 @default.
- W4366224579 cites W3036354112 @default.
- W4366224579 cites W3042531315 @default.
- W4366224579 cites W3112160686 @default.
- W4366224579 cites W3138125503 @default.
- W4366224579 cites W3210894270 @default.
- W4366224579 cites W3211572072 @default.
- W4366224579 doi "https://doi.org/10.3389/pore.2023.1610951" @default.
- W4366224579 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37139142" @default.
- W4366224579 hasPublicationYear "2023" @default.
- W4366224579 type Work @default.
- W4366224579 citedByCount "0" @default.
- W4366224579 crossrefType "journal-article" @default.
- W4366224579 hasAuthorship W4366224579A5002146164 @default.
- W4366224579 hasAuthorship W4366224579A5012053129 @default.
- W4366224579 hasAuthorship W4366224579A5017605264 @default.
- W4366224579 hasAuthorship W4366224579A5028018613 @default.
- W4366224579 hasAuthorship W4366224579A5048901694 @default.
- W4366224579 hasBestOaLocation W43662245791 @default.
- W4366224579 hasConcept C126322002 @default.
- W4366224579 hasConcept C143998085 @default.
- W4366224579 hasConcept C2777195454 @default.
- W4366224579 hasConcept C2779761222 @default.
- W4366224579 hasConcept C2993291352 @default.
- W4366224579 hasConcept C526584372 @default.
- W4366224579 hasConcept C71924100 @default.
- W4366224579 hasConceptScore W4366224579C126322002 @default.
- W4366224579 hasConceptScore W4366224579C143998085 @default.
- W4366224579 hasConceptScore W4366224579C2777195454 @default.
- W4366224579 hasConceptScore W4366224579C2779761222 @default.
- W4366224579 hasConceptScore W4366224579C2993291352 @default.
- W4366224579 hasConceptScore W4366224579C526584372 @default.
- W4366224579 hasConceptScore W4366224579C71924100 @default.
- W4366224579 hasLocation W43662245791 @default.
- W4366224579 hasLocation W43662245792 @default.
- W4366224579 hasLocation W43662245793 @default.
- W4366224579 hasOpenAccess W4366224579 @default.
- W4366224579 hasPrimaryLocation W43662245791 @default.
- W4366224579 hasRelatedWork W1984760639 @default.
- W4366224579 hasRelatedWork W2000364076 @default.
- W4366224579 hasRelatedWork W2011960454 @default.
- W4366224579 hasRelatedWork W2041009905 @default.
- W4366224579 hasRelatedWork W2110436471 @default.
- W4366224579 hasRelatedWork W2140359240 @default.
- W4366224579 hasRelatedWork W2275976839 @default.
- W4366224579 hasRelatedWork W2434470850 @default.
- W4366224579 hasRelatedWork W2588112983 @default.
- W4366224579 hasRelatedWork W2737452427 @default.
- W4366224579 hasVolume "29" @default.
- W4366224579 isParatext "false" @default.
- W4366224579 isRetracted "false" @default.
- W4366224579 workType "article" @default.